Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
44 Cards in this Set
- Front
- Back
Macule
|
Cercumscribed flat alteration in color <1cm
Not palpable |
|
Patch
|
circumscribed flat alteration in the skin > (=) 1 cm
not palpable |
|
Papule
|
circumscribed elevation of skin <1 Cm
palpable |
|
Plaque
|
circumscribe elevation of skin >1cm
Palpable |
|
Nodule
|
circumscribed mass 1-2cm
palpable Not necessarily raised because it could be in dermis or subcutis subcutaeneous indurated quality |
|
Vesicle
|
sharply circumscribed lesion
< 1cm contains transparent free fluid |
|
Bulae
|
sharply circumscribed lesion
>1cm contains transparent free fluid |
|
Pustule
|
circumscribed lesion
<1cm >1cm : lakes of pus vesicle with pus |
|
Wheal
|
(hive)
transient circumscribed elevated edematous lesion appears and disappears relatively rapidly - dermatographism: stroke the skin and you will get a wheal where you stroked. no permanent skin change |
|
Telangiectasia
|
-Dilated superficial capillaries
-Capillaries are in the dermis -Corticosteroid would cause this |
|
Crust
|
-Dried exudate, may have been serous, purulent, or hemorrhagic
-If the pt scratches something oozes, it will form a crust |
|
excoration
|
-Hemorrhagic excavation of the skin resulting from scratching
-May be shallow or deep, linear or punctate -Many people will just scratch at their skin if they have anything raised. |
|
lichenification
|
-thickening of the skin
-exagerated skin creases -Hyperpigmentation in darker patients and dyspigmentation in everyone else. |
|
Lichenoid
|
flat topped papules
|
|
Necrosis
|
death of the skin
black in color necrolysis: superficial necrosis |
|
Scar
|
Destructive natural process that has involved the dermis
two types A)hypertrophic thick and raised B)Atrophic pitting |
|
eschar
|
-Plaque covering an ulcer. Like a crust but a lot thicker.
-Black, strap-like tissue. -Occurs when abscess is deep. This takes a lot longer to lift off because the underlying tissue must heal. -implies underlying extensive tissue necrosis, infarcts, deep burns, or gangrene. |
|
scale
|
flat plate or flake of stratum corneum
Fine (pityriasiform) Thick (micaceious) (psoriasis) |
|
exfoliation
|
splitting off of stratum corneum in fine scales or sheets
|
|
Fissure
|
linear split or gap in the skin surface
|
|
Poikiloderma
|
Triad of hypo/hyperpigmentation, atrophy, and telangiectasias
Will also have erythema |
|
vegetative
|
proliferation of close set papillomatous masses
|
|
Erosion
|
partial break in the epidermis
heals without scarring follows a blister |
|
Ulcer
|
full thickness loss of the epidermis
heals with scarring |
|
Atrophy
|
thinning and transparency of the skin
caused by diminution wrinkling and translucency of skin with loss of markings |
|
sclerosis
|
circumscribed or diffuse hardening of the skin
|
|
Comedo
|
Keratin, sebum,microorganisms and epithelial cells debris within a dilated folicular opening
Open vs Closed |
|
Burrow
|
tunnel made in the skin by parasite or larva
|
|
Sinus Tract
|
elongated opening to a surface at one end an terminating in a blind sac
|
|
Fistula
|
elongated channel which communicated between two surfaces
|
|
Cyst
|
sac containing fluid or semisolid material wit an epithelial lining
|
|
Abscess
|
localized collection of pus larger than a pustule
|
|
Petechia/ Ecchymosis
|
Non-blanching extravasated blood
macules<3mm petechia macules>3mm ecchymosis |
|
Hematoma
|
extravasation of blood of such a size as to cause a visible swelling
|
|
Approach to a dermatologic patient
|
-Symptoms (fever, pain, pruritus)
-Duration (acute, subacute, chronic, intermittent) -Basic morphology (macules, patches, papules, plaques, vesicles, pustules) -Secondary morphologies and arrangements (solitary, generalized, annular, linear) -Distribution (arms, feet, etc) -Color (be specific... not just "red") -Lab findings (not set in stone... they have to match what you see) |
|
Subacute eruptions
|
-Appear gradually
-Don't persist after treatment (may require maintenance) -May become chronic *parasitic infestation (scabies/pediculosis) *some neoplasms *some infections (dermatophytosis, tinea versicolor) *acne vulgaris *rosacea |
|
Chronic eruptions
|
-Usually a gradual appearance
-May persist for long periods despite treatment -may have a subacute phase and then it will persist. |
|
Acute Eruptions
|
-sudden onset (days to hrs)
-often resides after short time *contact dermatitis *urticaria *infection *bites/stings *drug eruptions *vasculitis |
|
Intermittent eruptions
|
-resolve and then recur later
*urticaria (chronic form) *atopic dermatitis *erythema multiforme |
|
Keratoderma
|
-hyperkeratotic thickening of keratin layer
-can be congenital or mechanical -example: people that write a lot can form it on their finger. |
|
Acne Vulgaris
|
*Common (adolescents, 30-85%)
*impact on self image *management not always optimal (Myths, trivialized, undertreated) Common pitfalls: *lesion types not properly identified *severity not graded *treatment not properly correlated Appropriate follow-up and documentation (initial benefit = 4-8 wks, peak benefit = 3-4 months) Age Correlations: Preteen: Location-centrofacial, pattern - comedonal Teens: Location - face, trunk, pattern - mixed Adult Females: Location- perioral, chin jawline, upper neck, Pattern: Inflammatory Acne Pathophysiology: *excess sebum production *comedogenesis *p.acnes proliferation *inflammation Acne Pathogenesis: *Microcomedones *comedone (open/closed) *superficial inflammation (papules/pustules) *Deep inflammation (cysts/nodules) *Repair (normal skin, pigmentation, scarring) Ductal Hyperproliferation leads to Inflammatory Cascade. (slide 10) |
|
Acne Therapy
|
Efficacy Triad:
*Prevent comedogenesis *Reduce inflammation *Reduce P. Acne's impact Topical Therapy Selection -Anti-inflammatory therapy: Benzoyl peroxide, topical antibiotics, topical retinoids (additive benefit - lesion reduction, P. acnes suppression, reduced development of resistant P. acne strain) Anti-comedonal Therapy: Topical Retinoids *half of the backbone of the therapy. Initial maintenance therapy and it reduces inflammatory lesions. *2-8 wks for initial visible benefit *peak effect at 3-4 months (important patient education) Choice and Preference of drugs is based on efficacy, tolerability, and skin type Anti-Inflammatory: Benzoyl peroxide *Half of the backbone *Most potent anti-biotic *Reduction in inflammatory lesions *Prevents development of resistant strains *Prevents continued emergence and proliferation of already existent P. acnes strains Topical anti-biotics: *Direct anti-inflammatory effect *used only in combination therapy Oral Anti-biotic therapy (Acne and Rosacea) Erythromycin** - GI upset, drug-drug interactions, no routine labs Tetracycline - food-drug interactions, photosensitivity, pseudo tumor with all, no routine labs Doxycycline** - Photosensitivity, esophageal irritation, hypersensitivity (rare) Minocycline - dizzy, pigmentation, systemic reactions (rare), hypersensitivity (acute), autoimmune (chronic) Combination Therapy: Morning - benzoyl peroxid/antibiotic Evening - Topical Retinoids Reasons for treatment failure: *Poor compliance *P. acne resistance *Drug interactions *Underlying endocrinopathy *Exogenous Factors Oral Isotretinoin Therapy: *Candidate selection (refractory nodulocystic acne) *Prescribed course (20 wks) *baseline patient education and screening (hyperlipidemia, pregnancy, psychological/psychosocial) *Lab tests *Potential adverse reaction and warnings Hormonal Therapy: *use in women with androgen excess and normal serum *Oral contraceptives: ovarian suppression of androgen production *Spironolactone, Flutamide, Cypoterone acetate: androgen receptor blockage Corticosteroids: adrenal suppression of androgen production |
|
Rosacea
|
-Common in adulthood, all races/both sexes (Celtic skin type)
-Chronic-recurrent -idiopathic -Worsened by topical corticosteroids Four Components: -Vascular: erythema and telangiectasia -Ocular: Blepharitis, conjunctivitis, keratitis -Sebaceous: Phymas -Inflammatory: erythema, papules, pustules Therapy: Agents reduce lesion counts, reduce erythema, and decrease associated symptoms. Agents: sulfacetamide (sulfur), metronidazole (cream, lotion, gel), Azelaic acid gel, Clindamycin and erythromycin (based on skin type) Clinical Features: Presentation: central facial erythema, papules, pustules, telangiectasias, absence of comedones. (variable intensity) Therapy: Efficacy Triad: avoid flare factors, clear current disease, maintain remission Leave on formulas, therapeutic cleansers, non-medicated cleansers/emollients. Systemic therapy: oral antibiotic agents **No cure! Long-term control Flare factors: heat, alcohol, topical corticosteroids. Therapy Tier: Mild-Moderate: topical metronidazole, azelaic acid, sulfacetamide/sulfur Moderate-Severe: Add oral antibiotic, subantimicrobial dose doxycycline *antibiotic tapered, long-term with topical therapy Expectations: reduce papules/pustules, reduce erythema, no effect on telangiectasias Duration: 2-3 months for initial benefit + chronic maintenance |
|
Perioral Dermatitis
|
-iodiopathic, young females, topical corticosteroids
Presentation: *confluent or broken ring (pink erythema), small papules, pervermillion sparing, may be perinasal or periocular Treatment: *avoid irritants *it's not acne (no benzoyl peroxide or topical retinoids) *It's not contact dermatitis (no corticosteroid) *Topical therapy: clindamycin phosphate (gel/lotion), sulfacetamide (lotion/cream) *Systemic therapy: Oral tetracycline/doxycycline/minocycline (full dose x 2-3 wks and then half dose x 2-3 wks) *May recur in some cases - restart topical Rx first |